The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The sequencing of lanreotide (LAN) after octreotide LAR (OCT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
 
Wasif M. Saif
Consulting or Advisory Role - EMD Serono
Speakers' Bureau - Amgen; Celgene; Genentech; Ipsen; Lexicon; Novartis
Research Funding - Celgene (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); NanoCarrier; Pharmacyclics; Taiho Pharmaceutical (Inst)
 
Rohan Parikh
Employment - RTI Health Solutions
 
David Ray
Employment - Ipsen
 
James A. Kaye
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Bristol-Myers Squibb (I); Church & Dwight (I); Colgate (I); CVS Health (I); EI Dupont (I); Express Scripts (I); Gilead Sciences (I); Johnson & Johnson (I); Mettler Toledo (I); Novartis (I); Stericycle (I); United Health Group (I); Varian Medical Systems (I); Walgreens Boots Alliance (I)
Research Funding - Actelion (Inst); Agios (Inst); Akebia Therapeutics (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CPI Global CRO (Inst); CSL Behring (Inst); Dendreon (Inst); Dova Pharmaceuticals (Inst); Eisai (Inst); GlaxoSmithKline UK Ltd. (Inst); Global Blood Therapeutics (Inst); Glycomimetics (Inst); Helsinn Healthcare (Inst); INC Research (Inst); Ipsen (Inst); ISTARI Oncology (Inst); Janssen Scientific Affairs (Inst); LEO Pharma (Inst); Lexicon (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Merck KGaA (Inst); Millennium (Inst); National Pharmaceutical Council (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Quintiles (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Tesaro (Inst); Teva (Inst)
 
Samantha K Kurosky
Employment - RTI Health Solutions
 
Katharine Thomas
No Relationships to Disclose
 
Thomas Beveridge
Employment - Ipsen
 
Beloo Mirakhur
Employment - ipsen; ipsen
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Catherine A Lubeck
Employment - Ipsen
 
Saurabh P Nagar
Employment - RTI Health Solutions
 
Heloisa Soares
No Relationships to Disclose